Related Experiment Video
Updated: Oct 13, 2025
09:30
Using Nanoplasmon-Enhanced Scattering and Low-Magnification Microscope Imaging to Quantify Tumor-Derived Exosomes
Published on: May 24, 2019
7.5K
A Rapid and Facile Separation-Detection Integrated Strategy for Exosome Profiling Based on Boronic Acid-Directed
Yi-Ting Wang1, Ming-Di Cai1, Li-Li Sun2
1College of Life Science, Dalian Minzu University, Dalian, Liaoning 116600, China.
Analytical Chemistry
|November 18, 2021
Summary
This study presents a rapid 37-minute method for capturing and analyzing exosomes, crucial noninvasive tumor biomarkers. The technique achieves high accuracy in distinguishing cancer exosomes from serum, paving the way for advanced diagnostics.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Diagnostics
Background:
- Exosomes are vital noninvasive tumor biomarkers for cancer diagnosis and classification.
- Challenges exist in efficiently capturing and precisely analyzing exosomes from complex biological samples.
Purpose of the Study:
- To develop a rapid and sensitive method for exosome profiling using an integrated separation-detection strategy.
- To enable precise analysis and classification of exosomes for noninvasive cancer diagnosis.
Main Methods:
- Utilized boronic acid-modified g-C3N4 nanosheets (BCNNS) for antibody conjugation and exosome capture under physiological conditions.
- Implemented a fluorescence-based detection system with BCNNS for enhanced sensitivity.
- Employed a simple centrifugation step for exosome separation based on BCNNS dispersion properties.
Main Results:
- Achieved a sensitive detection limit of 2484 particles/mL for exosome profiling.
- Successfully distinguished exosomes from four different cell lines (HeLa, HepG2, MCF-7, MCF-10A) by altering antibodies.
- Demonstrated 100% positive prediction accuracy for serum samples from different individuals.
Conclusions:
- The developed 37-minute integrated strategy offers a sensitive and efficient approach for exosome analysis.
- The method shows significant potential for noninvasive cancer diagnosis and point-of-care testing due to its high accuracy and adaptability.
- Exosome phenotype profiling can be readily achieved by modifying the fused antibody, enhancing diagnostic capabilities.
